Aquestive Therapeutics (AQST) Return on Capital Employed Growth (3y) (2021 - 2026)
Aquestive Therapeutics (AQST) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,902.00 |
| 10 | Aquestive Therapeutics | 457.95 Mn | 457.95 Mn | 13.47 Mn | 14,955.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,955.00 |
| Dec 31, 2025 | 21,965.00 |
| Sep 30, 2025 | 19,146.00 |
| Jun 30, 2025 | 8,701.00 |
| Mar 31, 2025 | 5,303.00 |
| Dec 31, 2024 | 4,777.00 |
| Sep 30, 2024 | 7,278.00 |
| Jun 30, 2024 | 9,366.00 |
| Mar 31, 2024 | 6,288.00 |
| Dec 31, 2023 | 8,302.00 |
| Sep 30, 2023 | 3,210.00 |
| Jun 30, 2023 | -6,858.00 |
| Mar 31, 2023 | -10,126.00 |
| Dec 31, 2022 | -16,497.00 |
| Sep 30, 2022 | -5,914.00 |
| Jun 30, 2022 | -307.00 |
| Mar 31, 2022 | 3,862.00 |
| Dec 31, 2021 | 504.00 |
| Sep 30, 2021 | 643.00 |